Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management
Bioceres Crop Solutions (NASDAQ: BIOX) has received EPA federal registration for Rinotec, its innovative insecticide and nematicide platform. The product, which is exempt from residue tolerance requirements due to its negligible risk to human health and non-target organisms, has already secured approval for commercialization in Brazil.
The Rinotec platform features a unique metabolite-based approach to biologicals that enables significant dose reductions while maintaining the efficiency of synthetic chemical pesticides. This makes it suitable for both row and specialty crops. With registrations in both the U.S. and Brazilian markets, BIOX is now positioned to advance its regulatory and commercial strategies in two of the world's largest agricultural economies.
Bioceres Crop Solutions (NASDAQ: BIOX) ha ricevuto la registrazione federale EPA per Rinotec, la sua innovativa piattaforma di insetticidi e nematocidi. Il prodotto, esente dai requisiti di tolleranza ai residui grazie al suo rischio trascurabile per la salute umana e per gli organismi non bersaglio, ha già ottenuto l'approvazione per la commercializzazione in Brasile.
La piattaforma Rinotec presenta un approccio unico basato su metaboliti biologici che consente riduzioni significative delle dosi mantenendo l'efficacia dei pesticidi chimici sintetici. Questo la rende adatta sia per le colture in fila che per quelle speciali. Con registrazioni sia nel mercato statunitense che in quello brasiliano, BIOX è ora in posizione di avanzare le sue strategie regolatorie e commerciali in due delle più grandi economie agricole del mondo.
Bioceres Crop Solutions (NASDAQ: BIOX) ha recibido la aprobación federal de la EPA para Rinotec, su innovadora plataforma de insecticidas y nematicidas. El producto, que está exento de los requisitos de tolerancia a residuos debido a su riesgo insignificante para la salud humana y los organismos no objetivo, ya ha obtenido la aprobación para su comercialización en Brasil.
La plataforma Rinotec presenta un enfoque único basado en metabolitos biológicos que permite reducciones significativas de dosis manteniendo la eficacia de los pesticidas químicos sintéticos. Esto la hace adecuada tanto para cultivos en hileras como para cultivos especiales. Con registros en los mercados de EE. UU. y Brasil, BIOX ahora está posicionada para avanzar en sus estrategias regulatorias y comerciales en dos de las economías agrícolas más grandes del mundo.
Bioceres Crop Solutions (NASDAQ: BIOX)는 혁신적인 살충제 및 선충제 플랫폼인 Rinotec에 대해 EPA 연방 등록을 받았습니다. 이 제품은 인체 건강 및 비표적 생물에 대한 위험이 미미하여 잔여물 허용 기준에서 면제되며, 이미 브라질에서 상업화 승인을 받았습니다.
Rinotec 플랫폼은 생물학적 물질에 대한 독특한 대사물 기반 접근 방식을 특징으로 하여 합성 화학 살충제의 효율성을 유지하면서 상당한 용량 감소를 가능하게 합니다. 이는 줄기 작물과 특수 작물 모두에 적합합니다. 미국과 브라질 시장에서 등록을 마친 BIOX는 이제 세계에서 가장 큰 두 농업 경제에서 규제 및 상업 전략을 진전시킬 수 있는 위치에 있습니다.
Bioceres Crop Solutions (NASDAQ: BIOX) a reçu l'enregistrement fédéral de l'EPA pour Rinotec, sa plateforme innovante d'insecticides et de nématicides. Le produit, qui est exempt des exigences de tolérance aux résidus en raison de son risque négligeable pour la santé humaine et les organismes non ciblés, a déjà obtenu l'approbation pour sa commercialisation au Brésil.
La plateforme Rinotec présente une approche unique basée sur des métabolites biologiques qui permet des réductions de doses significatives tout en maintenant l'efficacité des pesticides chimiques synthétiques. Cela la rend adaptée tant aux cultures en rangées qu'aux cultures spéciales. Avec des enregistrements sur les marchés américain et brésilien, BIOX est désormais en position d'avancer ses stratégies réglementaires et commerciales dans deux des plus grandes économies agricoles du monde.
Bioceres Crop Solutions (NASDAQ: BIOX) hat die EPA-Bundesregistrierung für Rinotec, seine innovative Plattform für Insektizide und Nematizide, erhalten. Das Produkt, das aufgrund seines vernachlässigbaren Risikos für die menschliche Gesundheit und nicht-zielgerichtete Organismen von den Rückstandsgrenzwerten befreit ist, hat bereits die Genehmigung zur Vermarktung in Brasilien erhalten.
Die Rinotec-Plattform bietet einen einzigartigen metabolitbasierten Ansatz für biologische Produkte, der signifikante Dosisreduktionen ermöglicht und gleichzeitig die Effizienz synthetischer chemischer Pestizide aufrechterhält. Dies macht sie sowohl für Reihen- als auch für Spezialkulturen geeignet. Mit Registrierungen sowohl auf dem US-amerikanischen als auch auf dem brasilianischen Markt ist BIOX nun in der Lage, seine regulatorischen und kommerziellen Strategien in zwei der größten Agrarökonomien der Welt voranzutreiben.
- EPA registration secured for Rinotec platform, enabling U.S. market entry
- Product already approved in Brazil, accessing two major agricultural markets
- Exempt from residue tolerance requirements, indicating strong safety profile
- Reduced dosage requirements while maintaining synthetic pesticide efficiency
- None.
Rinotec has already been approved for commercialization in
“The EPA’s approval marks a key milestone in our efforts to bring transformative innovation to growers and the agriculture market,” said Milen Marinov, Chief Commercial Officer of Bioceres Crop Solutions. “The Rinotec platform is unique in its metabolite-based approach to biologicals, enabling substantial dose reductions while maintaining the efficiency and consistency of synthetic chemical pesticides. This makes it an ideal solution for row and specialty crops alike.”
“We are thrilled to achieve this important regulatory milestone for our new generation crop protection product,” said Federico Trucco, CEO of Bioceres Crop Solutions. “By equipping farmers with safer, more sustainable pest management solutions, we’re driving meaningful progress toward a more resilient global food system while maintaining robust productivity and environmental stewardship.”
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.
Forward-looking statements
This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals, including factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311702564/en/
Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com
Source: Bioceres Crop Solutions
FAQ
What is the significance of EPA registration for Bioceres' Rinotec platform (BIOX)?
In which major markets has BIOX's Rinotec received regulatory approval?
What are the key advantages of BIOX's Rinotec platform for agricultural use?
How does Rinotec's metabolite-based approach differ from traditional pesticides?
